News & Events about Hookipa Pharma Inc.
NEW YORK and VIENNA, Austria, June 10, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the Compensation Committee of the Companys Board of Directors ...
Thinking about buying stock in Hookipa Pharma, Ford Motor, JPMorgan, Spotify Technology, or Wynn Resorts? Thinking about buying stock in Hookipa Pharma, Ford Motor, JPMorgan, Spotify Technology, or Wynn Resorts? PR Newswire NEW YORK, May 1, 2023 NEW YORK, May 1, 2023 /PRNewswire...
NEW YORK and VIENNA, Austria, April 26, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that a Trial in Progress poster on its ongoing Phase 1/2 clinical study (...
NEW YORK and VIENNA, March 08, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that it will release fourth quarter and full year 2022 financial results before ...